Circulating angiogenic and inflammatory biomarkers profiling in patients with hereditary hemorrhagic telangiectasia
Eur J Intern Med. 2026 Sep 23:107200. doi: 10.1016/j.ejim.2026.107200. Online ahead of print. ABSTRACT BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an inherited vascular disorder affecting BMP9-ALK1-endoglin signaling, leading to vascular malformations. HHT is marked by recurrent bleeding (mostly epistaxis and gastrointestinal) that can result in severe anemia. Thus, there is a need for circulating biomarkers […]



